Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Duca

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid TumorsSylvie Rottey, Jeffrey Clarke, Kyaw Aung, et al.
Frontiers in Oncology|April 25, 2022
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary ModelJacopo Azzollini, Andrea Vingiani, Luca Agnelli, et al.
Cancers|June 4, 2020
A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid TumorsFilippo de Braud, Jean-Pascal H Machiels, Daniela Boggiani, et al.
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline <i>BRCA1/2</i> pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
BMJ Open|May 16, 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational studyValentina De Micheli, Luca Agnelli, Elena Conca, et al.
JCO Precision Oncology|June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment RecommendationsFederico Nichetti, Marta Brambilla, Matteo Duca, et al.
Faraday Discussions|November 20, 2014
Carbon electrode interfaces for synthesis, sensing and electrocatalysis: general discussionYury Gogotsi, Richard McCreery, Stephen M Lyth, et al.
Faraday Discussions|November 20, 2014
Role of surface contaminants, functionalities, defects and electronic structure: general discussionRichard McCreery, Chi-Chang Hu, Julie Macpherson, et al.
Frontiers in Oncology|August 22, 2025
Genomic instability and <i>CCNE1</i> amplification as emerging biomarkers for stratifying high-grade serous ovarian cancerElena Conca, Daniele Lorenzini, Emanuela Minna, et al.
Faraday Discussions|November 20, 2014
The many faces of carbon in electrochemistry: general discussionRobert Dryfe, George Zheng Chen, Domnik Bayer, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid TumorsSylvie Rottey, Jeffrey Clarke, Kyaw Aung, et al.
Frontiers in Oncology|April 25, 2022
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary ModelJacopo Azzollini, Andrea Vingiani, Luca Agnelli, et al.
Cancers|June 4, 2020
A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid TumorsFilippo de Braud, Jean-Pascal H Machiels, Daniela Boggiani, et al.
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline <i>BRCA1/2</i> pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
BMJ Open|May 16, 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational studyValentina De Micheli, Luca Agnelli, Elena Conca, et al.
JCO Precision Oncology|June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment RecommendationsFederico Nichetti, Marta Brambilla, Matteo Duca, et al.
Faraday Discussions|November 20, 2014
Carbon electrode interfaces for synthesis, sensing and electrocatalysis: general discussionYury Gogotsi, Richard McCreery, Stephen M Lyth, et al.
Faraday Discussions|November 20, 2014
Role of surface contaminants, functionalities, defects and electronic structure: general discussionRichard McCreery, Chi-Chang Hu, Julie Macpherson, et al.
Frontiers in Oncology|August 22, 2025
Genomic instability and <i>CCNE1</i> amplification as emerging biomarkers for stratifying high-grade serous ovarian cancerElena Conca, Daniele Lorenzini, Emanuela Minna, et al.
Faraday Discussions|November 20, 2014
The many faces of carbon in electrochemistry: general discussionRobert Dryfe, George Zheng Chen, Domnik Bayer, et al.
Pageof 4